The Intercalated Nucleus of the Medulla (Ic) is a cluster of GABAergic and glycinergic neurons in the medulla oblongata that serves as a critical relay station for autonomic and respiratory control, particularly involved in baroreceptor reflexes, blood pressure regulation, and cardiorespiratory integration. This nucleus plays a significant role in neurodegenerative diseases affecting brainstem autonomic centers.[1] [1:1]
| Property | Value | [2]
|----------|-------| [3]
| Category | Cell Types | [4]
| Brain Region | Brainstem (Medulla) | [5]
| Lineage | Autonomic regulatory neuron | [6]
| Key Markers | GAD1/2, GlyT2, nNOS, PV, CB | [7]
| Allen Atlas ID | N/A | [8]
| Taxonomy | ID | Name / Label |
|---|---|---|
| Cell Ontology (CL) | CL:0002614 | neuron of the substantia nigra |
| Database | ID | Name | Confidence |
|---|---|---|---|
| Cell Ontology | CL:0002614 | neuron of the substantia nigra | Medium |
| Cell Ontology | CL:0005010 | renal intercalated cell | Medium |
The intercalated nucleus contains morphologically and neurochemically diverse neuron populations:
Key molecular markers:
The intercalated nucleus controls several vital autonomic functions:
The Ic nucleus is a key processor in the baroreceptor reflex arc, receiving input from carotid sinus and aortic arch baroreceptors via the nucleus tractus solitarius (NTS) and modulating sympathetic outflow through the ventrolateral medulla to maintain blood pressure homeostasis.[3:1]
In AD, the intercalated nucleus may be affected by:
The intercalated nucleus is relevant to PD in several ways:
MSA particularly targets the intercalated nucleus:
ALS affects the medulla through:
The intercalated nucleus may serve as a biomarker source:
The study of Intercalated Nucleus Of The Medulla has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Benarroch EE. Brainstem respiratory control: substrates of respiratory failure in neurodegenerative disease. Neurology. 2021. 2021. ↩︎ ↩︎
Jellinger KA. Neuropathology of multiple system atrophy: new thoughts about pathogenesis. Acta Neuropathol. 2019. 2019. ↩︎ ↩︎
Saper CB, Fuller DJ, Pedersen NP, et al. Sleep state switching. Neuron. 2010. 2010. ↩︎ ↩︎
Benarroch EE. Autonomic dysfunction in neurodegenerative diseases. Handb Clin Neurol. 2021. 2021. ↩︎ ↩︎
Woolf NJ, Butcher LL. Cholinergic systems mediate action from movement to higher consciousness. Behav Brain Res. 2011. 2011. ↩︎ ↩︎
Braak H, Del Tredici K. Neuroanatomy and pathology of sporadic Parkinson's disease. Adv Anat Embryol Cell Biol. 2023. 2023. ↩︎ ↩︎
Pfeffer RF. Gastrointestinal dysfunction in Parkinson's disease. Parkinsonism Relat Disord. 2021. 2021. ↩︎ ↩︎
Jellinger KA. Prevalence of alpha-synuclein in medullary autonomic nuclei in incidental Lewy body disease. Acta Neuropathol. 2020. 2020. ↩︎ ↩︎
Vuckovic MG, Rimpilainen I, K Kiss ZHT, et al. Vagus nerve stimulation as a novel therapeutic approach for neurodegenerative disorders. J Neural Transm. 2022. 2022. ↩︎